IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Multiple Sclerosis, Chronic Progressive
Centre Hospitalier de PAUmonoclonal_antibodyPhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
12 Active assets in the Multiple Sclerosis, Chronic Progressive cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
D-thioctic acid Rebecca Spain | Phase 2/3 | BB |
Cyclophosphamide Bruce Cree | Phase 3 | BB |
Masitinib AB Science | Phase 3 | B |
Cladribine Queen Mary University of London | Phase 2/3 | B |
N-Acetyl-L-Cysteine University of California, San Francisco | Phase 2 | B |
View all 29 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →